What Makes Y Family Pols Potential Candidates for Molecular Targeted Therapies and Novel Biotechnological Applications

Publisher： Bentham Science Publishers

E-ISSN： 1875-5666|14|1|96-114

ISSN： 1566-5240

Source： Current Molecular Medicine, Vol.14, Iss.1, 2014-01, pp. : 96-114

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Molecular Pathogenesis of Non Muscle-Invasive Bladder Cancer: Implications for Novel Targeted Therapies

By  

Current Molecular Medicine, Vol. 11, Iss. 8, 2011-11 ,pp. : 623-632

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Targeted Therapies and Combinations for the Treatment of Multiple Myeloma

By  

Cardiovascular & Haematological Disorders - Drug Targets(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders), Vol. 13, Iss. 1, 2013-03 ,pp. : 2-15

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular-Targeted and Cell-Based Therapies for Sjogren’s Syndrome

By  

Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Immunology, Endocrine and Metabolic Agents), Vol. 12, Iss. 2, 2012-06 ,pp. : 73-79

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Hot Topic: Biomarkers, Molecular Imaging, and Novel Therapies of Cancer)

By  

Current Molecular Medicine, Vol. 13, Iss. 3, 2013-03 ,pp. : 331-332

Bentham Science Publishers

Access to resources Recommend Favorite

What Makes a Pluripotency Reprogramming Factor?

By  

Current Molecular Medicine, Vol. 13, Iss. 5, 2013-06 ,pp. : 806-814

Bentham Science Publishers

Access to resources Recommend Favorite